Overview

Randomized Study for Patients With Follicular Lymphoma Needing Treatment

Status:
Completed
Trial end date:
2004-01-01
Target enrollment:
Participant gender:
Summary
2 parallel studies. - For young patients (18-60 years): randomization between CHVP + interferon for 18 months and 4 CHOP followed by autotransplant after TBI - For elderly patients (>60 years): randomization between CHVP + interferon for 18 months and fludarabine 5 days every months for 6 months
Phase:
Phase 3
Details
Lead Sponsor:
Lymphoma Study Association
Treatments:
Fludarabine
Fludarabine phosphate
Interferons